Lidocaine And Prilocaine
NDC Package 0121-1002-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Lidocaine And Prilocaine is cream USP, 2.5%/2.5% (a eutectic mixture of lidocaine 2.5% and prilocaine 2.5%) is indicated as a topical anesthetic for use on:normal intact skin for local analgesia.Genital mucous membranes for superficial minor surgery and as pretreatment for infiltration anesthesia.Lidocaine and Prilocaine Cream, 2.5%/2.5% is not recommended in any clinical situation when penetration or migration beyond the tympanic membrane into the middle ear is possible because of the ototoxic effect observed in animal studies (see WARNINGS). Marketed by Pai Holdings, Llc Dba Pai Pharma, this product is identified by NDC 0121-1002 and is authorized under FDA application ANDA205887.

Identification & Billing

NDC Package Code
0121-1002-30
Package Description
1 TUBE in 1 CARTON / 30 g in 1 TUBE
Product Code
0121-1002
11-Digit Billing Format
00121100230
Billing Unit
GM - Billing unit of "gram" is used when a product is measured by its weight.
Units Per Package
30 GM

Clinical Specifications

Proprietary Name
Lidocaine And Prilocaine
Dosage Form
-
Usage Information
Lidocaine and Prilocaine Cream USP, 2.5%/2.5% (a eutectic mixture of lidocaine 2.5% and prilocaine 2.5%) is indicated as a topical anesthetic for use on:normal intact skin for local analgesia.Genital mucous membranes for superficial minor surgery and as pretreatment for infiltration anesthesia.Lidocaine and Prilocaine Cream, 2.5%/2.5% is not recommended in any clinical situation when penetration or migration beyond the tympanic membrane into the middle ear is possible because of the ototoxic effect observed in animal studies (see WARNINGS).

Regulatory & Marketing

Labeler Name
Pai Holdings, Llc Dba Pai Pharma
FDA Application #
ANDA205887
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
02-06-2025
End Marketing Date
08-31-2026
Listing Expiration
08-31-2026
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0121-1002-30 identifies a specific commercial package of 1 tube in 1 carton / 30 g in 1 tube of Lidocaine And Prilocaine, labeled by Pai Holdings, Llc Dba Pai Pharma. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Pai Holdings, Llc Dba Pai Pharma on February 06, 2025. The current certification is valid through August 31, 2026.

How is this Pai Holdings, Llc Dba Pai Pharma product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00121100230. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0121-1002-30
11-Digit CMS (5-4-2)
00121-1002-30

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.